Molekulare Targets beim Kolonkarzinom: VEGF, EGFR – was noch?

ISSN： 0172-8113

Source： Der Pathologe, Vol.29, Iss.2, 2008-11, pp. : 200-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

EGFR-Blockade mit Gefitinib. Erfolge beim NSCLC

Oncology Research and Treatment, Vol. 27, Iss. 3, 2004-07 ,pp. : 322-323

Karger

Access to resources Recommend Favorite

Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer

Oncology, Vol. 93, Iss. 3, 2017-05 ,pp. : 191-196

Karger

Access to resources Recommend Favorite

Molekulare Pathogenese: Ihre Bedeutung für die zielgerichtete Therapie beim kolorektalen Karzinom

By Kloor M. Michel S. Knebel Doeberitz M.

Der Pathologe, Vol. 29, Iss. 2, 2008-11 ,pp. : 196-199

Springer Publishing Company

Access to resources Recommend Favorite

Histologie-basierter Algorithmus der molekularen Diagnostik des epidermalen Wachstumsfaktor-Rezeptorgens (Epidermal Growth Factor Receptor, EGFR) beim nicht-kleinzelligen Lungenkarzinom (non-small cell lung cancer, NSCLC) *

By Popper Helmut

Wiener klinische Wochenschrift, Vol. 123, Iss. 9-10, 2011-05 ,pp. : 316-321

Springer Publishing Company

Access to resources Recommend Favorite

MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer

Cytogenetic and Genome Research, Vol. 146, Iss. 1, 2015-07 ,pp. : 1-8

Karger

Access to resources Recommend Favorite